The number of people with susceptibility test result for rifampicin in North Macedonia
North Macedonia: The number of people with susceptibility test result for rifampicin was 100 in 2021. ▼ Falling
Latest (2021)
100
Change on year
up 23.5%
World rank
109th
of 155 countries
All-time high
136
in 2017
All-time low
81
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in North Macedonia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
North Macedonia recorded 100 for the number of people with susceptibility test result for rifampicin in 2021.
Compared with earlier readings it is up 23.5% on the previous year and down 26.5% over five years.
North Macedonia ranks 109th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in North Macedonia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 136 | — |
| 2018 | 128 | -5.9% |
| 2019 | 126 | -1.6% |
| 2020 | 81 | -35.7% |
| 2021 | 100 | +23.5% |
North Macedonia compared with similar countries
- North Macedonia's 100 is below the median for upper middle income countries, which is 880, 11% of the median. (46 countries reporting)
- North Macedonia's 100 is below the median for Europe & Central Asia, which is 229.5, 44% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 130 | 126 | 136 | 3 |
| 2020s | 90.5 | 81 | 100 | 2 |
Countries ranked near North Macedonia
More health data for North Macedonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,700 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0232 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.76 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in North Macedonia?
- The number of people with susceptibility test result for rifampicin in North Macedonia was 100 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in North Macedonia?
- The highest recorded value was 136 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in North Macedonia?
- The lowest recorded value was 81 in 2020.
- How does North Macedonia rank for the number of people with susceptibility test result for rifampicin?
- North Macedonia ranks 109th out of 155 countries with data for 2021.
- Where does this North Macedonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).